Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
12/2010
12/21/2010US7855198 Benzamide derivative or salt thereof
12/16/2010WO2010144055A1 Novel compounds and uses thereof
12/16/2010WO2010143734A1 Nitro group-containing ether compound and method for producing same
12/16/2010WO2010143700A1 Dihydroxyhexenoic acid ester and method for producing same
12/16/2010WO2010111211A3 Heteroatom-containing polymers and metathesis polymerization methods for making same
12/16/2010US20100317854 Novel aminodicarboxylic acid derivatives having pharmaceutical properties
12/16/2010US20100316631 Water Soluble Curcumin-Based Compounds
12/15/2010CN101918352A Inhibitors of 17beta-hydroxysteroid dehydrogenase
12/15/2010CN101914023A Preparation method of optically pure 4-aryl-2-hydroxy-butyric ester
12/15/2010CN101171242B Process for producing vinylene carbonate
12/15/2010CN101121708B Method for synthesizing oxapium iodide and analogue thereof
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/09/2010WO2010096677A3 Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof
12/09/2010US20100311827 Chlorogenic acid derivatives and their use as anti-fungal agents
12/08/2010EP2259068A2 Capture compounds and methods for analyzing the proteome
12/08/2010EP2258696A1 Process for preparing enriched enantiomers of 3-(Benzo[1,3]dioxol-5-yl)-2-methylpropanal
12/08/2010EP2258681A2 Aromatic Derivatives as HIV Aspartyl Protease Inhibitors
12/08/2010EP2258680A2 Aromatic derivatives as HIV aspartyl protease inhibitors
12/08/2010EP2257559A1 Synthesis of cyclic carbonates
12/08/2010CN101910097A Process for the preparation of alkylene glycol
12/08/2010CN101906053A 酰胺衍生物 Amide derivatives
12/08/2010CN101555025B Preparation method of ammonia for coal-fired flue gas desulfurization and denitration by coproduction
12/08/2010CN101390852B Melanogenesis inhibitor and skin preparation containing the same
12/07/2010US7847110 Method for producing optionally substituted methylenedioxybenzene
12/07/2010US7846967 isolated from Cnidium officinale and Ligusticum chuanxiong; inhibiting melanocyte-stimulating hormone
12/07/2010US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
12/07/2010US7846890 3-acetate of [1aR-(1a alpha ,2 beta ,3 beta ,4a beta ,8aS)]-decahydro-2,4a,8,8-tetramethyl-cyclopropa[d]naphthalene-2,3-diol; 2,3-(dimethylmethylenedioxy)-1,8a-methano-2,4a,8,8-tetramethyldecahydronaphthalene; detergent, fabric softener, perfume, cologne, perfumed soap, paper, wipe, bleach etc.
12/02/2010WO2010138484A2 Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
12/02/2010WO2010136506A1 Process for the preparation of 4-fluoro-4-r-5-r'-1,3-dioxolane-2-ones
12/02/2010WO2010136037A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/02/2010US20100305131 Substituted Aminopropionic Derivatives as Neprilysin inhibitors
12/02/2010US20100303805 Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
12/02/2010CA2762137A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/01/2010EP2255009A2 Processes for preparing enantiomerically pure diol and dioxolane compounds
12/01/2010CN1922125B Alkyl acetal compound, process for producing the same, and lubricating oil composition
12/01/2010CN101903369A Leukotriene B4 inhibitors
12/01/2010CN101903363A 2-methylthioethyl-substituted heterocycles as feed additives
12/01/2010CN101899033A Chemical synthesis and preparation method of heliotropin
12/01/2010CN101898982A Npy y5 antagonists
11/2010
11/30/2010US7842705 Curcumin analogs with anti-tumor and anti-angiogenic properties
11/25/2010US20100298561 2-amino-bicyclo(3.1.0) hexane-2, 6-dicarboxylic ester derivative
11/25/2010US20100298347 Substituted 2-naphthoic acids as antagonists of gpr105 activity
11/25/2010US20100298330 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
11/25/2010US20100298168 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
11/24/2010EP2253620A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
11/24/2010EP1931650B1 Method for the production of dioxolane
11/24/2010EP1583972B1 Methods for identifying drug non-target proteins
11/24/2010CN201644064U Production system for glycerin ester of carbonic acid
11/24/2010CN1951932B [N-(3',4'methylenedioxy)phenylethyl] formamidobenzoic acid derivative, its preparation method and uses
11/23/2010US7838693 Process for the preparation of 3,5-di-O-acyl-2-fluoro-2-C-methyl-D-ribono-gamma-lactone
11/23/2010US7838692 Alkyl acetal compound, process for producing the same, and lubricating oil composition
11/23/2010CA2563022C Process for preparing 1,3-dioxolane derivatives
11/23/2010CA2459380C Reverse hydroxamic acid derivatives
11/23/2010CA2434775C Compounds for use in the treatment of skin conditions
11/23/2010CA2283132C Crosslinkable bi-sulphonyl derivatives and their uses for preparing ion-exchanging membranes
11/18/2010WO2010131274A1 Process for preparing hydrocinnamic aldehydes in enantiopure or enantiomerically enriched form
11/18/2010WO2010131054A1 Redox drug derivatives
11/18/2010US20100292500 Npy y5 antagonist
11/18/2010US20100292373 Adducts of levulinic derivatives with epoxidized fatty acid esters and uses thereof
11/18/2010US20100292317 Antimicrobial and radioprotective compounds
11/18/2010US20100292240 Sulfonamide compounds
11/18/2010US20100291003 Histone deacetylase inhibitors
11/18/2010CA2762022A1 Redox drug derivatives
11/17/2010EP1032377B1 Substituted 2-aminoacetamides and the use thereof
11/17/2010CN101889006A Intermediates and methods for making zearalenone macrolide analogs
11/17/2010CN101889005A Intermediates in the synthesis of zearalenone macrolide analogs
11/17/2010CN101885719A Spiroketal-substituted cyclic ketoenols
11/17/2010CN101210006B Method for preparing vinylene carbonate
11/16/2010US7834054 Hydroxamates as therapeutic agents
11/11/2010WO2010128634A1 Process for producing 4,5-dialkyl-4,5-difluoro-1,3-dioxolan-2-one
11/11/2010US20100286204 Compound capable of inhibiting 17-beta hydroxysteriod dehydrogenase
11/10/2010EP2248796A1 2-methylene-5-substituted methylene cyclopentanone derivatives and use thereof
11/10/2010EP1896445B1 ( 6-FLU0R0-BENZ0[l, 3] DIOXOLYL) -MORPHOLIN-4-YL-METHANONES AND THEIR USE AS CBl LIGANDS
11/10/2010EP1637517B1 2-aminobicyclo 3.1.0 hexane-2,6-dicarboxylic ester derivative
11/10/2010CN101883761A New process for the synthesis of moguisteine
11/10/2010CN101883752A Method for producing carbonate compound
11/10/2010CN101883751A Method for producing carbonate compound
11/10/2010CN101235027B Xanthiphenylketamine crystal and its preparation method and medical use
11/09/2010US7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/09/2010US7829563 sleep disorders; (R)-2-[(S)1-(5-chloro-2-methoxy-phenyl)-3-(6-trifluoromethyl-pyridin-3-yl)-propylamino]-2-(4-fluoro-phenyl)-N-methyl-acetamide
11/09/2010US7829257 Alkaline developable photoresists
11/04/2010WO2010126811A1 Cxcr3 receptor antagonists
11/04/2010WO2010125134A1 N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010WO2010097811A4 Microwave induced single step green synthesis of some novel 2-aryl aldehydes and their analogues
11/04/2010WO2010048536A3 Processes for preparing lipids
11/04/2010US20100280282 Phosphatidyl oligoglycerols
11/04/2010US20100280261 Porous body precursors, shaped porous bodies, processes for making them, and end-use products based upon the same
11/04/2010US20100280252 Poly(ethylene glycol) containing chemically disparate endgroups
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010CA2759482A1 N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/03/2010EP1963260B1 Process for the production of ezetimibe and intermediates used in this process
11/03/2010CN1615295B Compounds for treatment of inflammation, diabetes and related disorders
11/03/2010CN101875650A Preparation process of N-ethyl-3,4-(methylenedioxy)aniline
11/02/2010US7825278 Central nervous system disorders; gamma aminobutyric acid (GABA) receptor complex modulators
11/02/2010US7825145 Antimicrobial and radioprotective compounds
11/02/2010US7825126 (N)-methanocarba adenine nucleosides contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, cardiac arrhythmias and cardioprotection
11/02/2010US7825105 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010124201A2 Compositions and methods for treatment of cardiovascular disease
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 183